Skip to content

Hemodynamic Effects of Negative Pressure Ventilation in Chronic Obstructive Pulmonary Disease

Hemodynamic Effects of Negative Pressure Ventilation in Chronic Obstructive Pulmonary Disease Assessed Using Non-Invasive Electrical Cardiometry

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04212559
Enrollment
30
Registered
2019-12-27
Start date
2018-01-01
Completion date
2019-12-31
Last updated
2020-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Brief summary

Negative pressure ventilation (NPV) is a non-invasive ventilation mode which provide better lung expansion. The major complication of NPV is decrease blood pressure and affects the hemodynamics. The effects of NPV on chronic obstructive pulmonary disease (COPD) patients with pulmonary rehabilitation program remains unknown.

Detailed description

Both of NPV or positive pressure ventilation (PPV) has impact of hemodynamics. NPV with cuirass ventilator increases venous return and leads to ventricular filling and increases cardiac output (CO); In contrast to NPV, the effect of PPV in most situations is a decreased venous return and leads to decreased CO. NPV improving ventilation and work of breathing in patients with chronic obstructive pulmonary disease (COPD).

Interventions

OTHERReceived negative pressure ventilation

Patients who received a negative pressure during inspiratory phase.

Sponsors

Fu Jen Catholic University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with COPD who received pulmonary rehabilitation program with NPV treatment

Exclusion criteria

* Recent exacerbation within 3-months * Existing of tracheostomy * Absence of NPV used * Required of oxygen supplement during NPV * Diagnosed of neuromuscular disease

Design outcomes

Primary

MeasureTime frameDescription
CO (cardiac output)20 minutesChange of Cardiac output before and after NPV treatment
SV (stroke volume)20 minutesChange of stroke volume before and after NPV treatment

Secondary

MeasureTime frameDescription
SpO220 minutesChange of oxygen saturation before and after NPV treatment
RR (respiratory rate)20 minutesChange of respiratory rate before and after NPV treatment

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026